Ireland
BioProbe Diagnostics is a biotechnology startup focused on delivering innovative diagnostics products to the market. Established in 2017 as a spinout from the National University of Ireland Galway, the company specializes in developing innovative PCR tests for the detection of microbial pathogens associated with water contamination in environmental and industrial processes.
With a strong team of scientists, innovators, and business experts, BioProbe Diagnostics is dedicated to developing and marketing these PCR test kits globally. Leveraging patented technologies, the company aims to revolutionize the global marketplace with rapid, accurate, cost-effective, and user-friendly PCR test kits. Their flagship product, Bio Lp-1, a transformative Legionella test kit, was honored with the prestigious EU Fast Track to Innovation Award in 2020.
In 2022, the company plans to launch Bio Lp-1 in collaboration with renowned international partners. The company has received a €71.43K grant investment from EASME - EU Executive Agency for SMEs in June 2018.
Operating in the biotechnology and health care industries, BioProbe Diagnostics is headquartered in Ireland.
